Category:Hiroki ISHIOKA
Appearance
Hiroki ISHIOKA
Executive Summary
Hiroki ISHIOKA is an inventor who has filed 2 patents. Their primary areas of innovation include HETEROCYCLIC COMPOUNDS (macromolecular compounds (2 patents), Antineoplastic agents (1 patents), HETEROCYCLIC COMPOUNDS (macromolecular compounds (1 patents), and they have worked with companies such as Astellas Pharma Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).
Patent Filing Activity
File:Hiroki ISHIOKA Monthly Patent Applications.png
Technology Areas
File:Hiroki ISHIOKA Top Technology Areas.png
List of Technology Areas
- C07D487/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
- A61P35/00 (Antineoplastic agents): 1 patents
- C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
Companies
File:Hiroki ISHIOKA Top Companies.png
List of Companies
- Astellas Pharma Inc.: 2 patents
Collaborators
- Eiji KAWAMINAMI (2 collaborations)
- Kenichi KAWAGUCHI (2 collaborations)
- Kazuyuki KURAMOTO (2 collaborations)
- Tomoyoshi IMAIZUMI (2 collaborations)
- Takahiro MORIKAWA (2 collaborations)
- Hisao HAMAGUCHI (2 collaborations)
- Sunao IMADA (2 collaborations)
- Mitsuaki OKUMURA (2 collaborations)
- Takeyuki NAGASHIMA (2 collaborations)
- Tomohiro YOSHINARI (1 collaborations)
- Hideyuki WATANABE (1 collaborations)
- Kohei INAMURA (1 collaborations)
- Ryo SATO (1 collaborations)
- Yohei SEKI (1 collaborations)
- Hiroki FUKUDOME (1 collaborations)
- Ikumi KURIWAKI (1 collaborations)
Subcategories
This category has the following 6 subcategories, out of 6 total.
E
H
K
T
Categories:
- Eiji KAWAMINAMI
- Kenichi KAWAGUCHI
- Kazuyuki KURAMOTO
- Pages with broken file links
- Tomoyoshi IMAIZUMI
- Takahiro MORIKAWA
- Hisao HAMAGUCHI
- Sunao IMADA
- Mitsuaki OKUMURA
- Takeyuki NAGASHIMA
- Tomohiro YOSHINARI
- Hideyuki WATANABE
- Kohei INAMURA
- Ryo SATO
- Yohei SEKI
- Hiroki FUKUDOME
- Ikumi KURIWAKI
- Hiroki ISHIOKA
- Inventors
- Inventors filing patents with Astellas Pharma Inc.